News | April 01, 2025
Akums launches Ripasudil + Timolol combination for glaucoma treatment
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
The new combination therapy offers a dual mechanism of action for superior intraocular pressure control
Brimonidine Tartrate and Timolol Maleate Ophthalmic Solution is indicated for the reduction of elevated intraocular pressure
According to IQVIATM sales data for the 12-month period ending March 2024, the Combigan Ophthalmic Solution, 0.2%|0.5% market achieved annual sales of approximately $290.0 million
The company has received six final approvals that includes Chlorpromazine Hydrochloride Tablets
Ocular hypertension affects over 5% of all adults; the eye does not properly drain fluid, causing eye pressure to build up
Dorzolamide Hydrochloride and Timolol Maleate Ophthalmic Solution USP, 2% and 0.5% has an estimated market size of US $80 million for twelve months ending December 2020 according to IQVIA
Subscribe To Our Newsletter & Stay Updated
